Document Detail

Vascular endothelial growth factor expression in nasal polyps of aspirin-intolerant patients.
MedLine Citation:
PMID:  22431874     Owner:  NLM     Status:  In-Data-Review    
OBJECTIVE: To study differences between aspirin-tolerant patients and aspirin-intolerant patients concerning vascular endothelial growth factor (VEGF) expression. Recent publications strongly suggest the involvement of VEGF and its receptors in the pathophysiologic process of nasal polyps.
DESIGN: We subjected 43 polyp specimens to semiquantitative immunohistochemical analysis. We quantified VEGF and its receptors (Flk, Flt, and neuropilin) in all samples. To gain insight into potential VEGF-mediated cellular responses, we determined proliferative (Ki67) and apoptotic (caspase 3) indices.
PATIENTS: Polyp samples were obtained from 22 aspirin-intolerant patients and from 21 aspirin-tolerant patients, and control specimens were obtained from 24 subjects with healthy nasal respiratory mucosa.
SETTING: Laboratory; Department of Otorhinolaryngology-Head and Neck Surgery, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
MAIN OUTCOME MEASURES: Expression levels of VEGF, VEGF receptors. and proliferative and apoptotic indices.
RESULTS: We found higher expressed levels of VEGF and neuropilin and stronger proliferation in nasal polyps from aspirin-tolerant and aspirin-intolerant patients compared with controls. In polyps from aspirin-intolerant patients, VEGF was expressed at considerably higher levels compared with those from aspirin-tolerant subjects. Apoptotic activity remained unchanged in all 3 groups.
CONCLUSIONS: Nasal polyps from aspirin-tolerant and aspirin-intolerant patients are characterized by strong proliferation and high levels of VEGF and neuropilin expression. Nasal polyps from aspirin-intolerant patients show distinctly increased VEGF levels. The relevance of these findings for future therapeutic approaches is yet to be determined.
Kai Fruth; Chengjing Zhu; Eduard Schramek; Johannes Angermair; Wassim Kassem; Boris R Haxel; Astrid Schneider; Wolf J Mann; Juergen Brieger
Related Documents :
22749434 - The role of repeat transesophageal echocardiography in patients without atrial thrombus...
7300004 - Serum lipid and lipoprotein profiles in patients with xanthomas: a correlative study on...
7664504 - Update on the treatment of hypercholesterolemia, with a focus on hmg-coa reductase inhi...
15350864 - Successful treatment of cutaneous leishmaniasis with lipid formulations of amphotericin...
615714 - Folate-responsive neurological and mental disorders: report of 16 cases. neuropsycholog...
21623214 - Vitamin d status in patients with chronic obstructive pulmonary disease who participate...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Archives of otolaryngology--head & neck surgery     Volume:  138     ISSN:  1538-361X     ISO Abbreviation:  Arch. Otolaryngol. Head Neck Surg.     Publication Date:  2012 Mar 
Date Detail:
Created Date:  2012-03-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8603209     Medline TA:  Arch Otolaryngol Head Neck Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  286-93     Citation Subset:  AIM; IM    
Department of Otorhinolaryngology-Head and Neck Surgery, University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstrasse 1, 55101 Mainz, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Congenital cholesteatoma: predictors for residual disease and hearing outcomes.
Next Document:  Treatment of recalcitrant chronic rhinosinusitis with integrative East-west medicine: a pilot study.